Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim vs Filgrastim for PBPC Mobilization in Multiple Myeloma
NCT00526734Phase 2Unknown
- Sponsor
- Erasmus Hospital
- Start
- Feb 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of pegfilgrastim in multiple myeloma (MM), sponsored by Erasmus Hospital. Status: unknown.
02
Drugs
pegfilgrastim
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00526734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526734.